相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
National survey on the susceptibility of Bacteroides fragilis group:: Report and analysis of trends in the united states from 1997 to 2004
D. R. Snydman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea
Paul Juang et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain
Francois Lamontagne et al.
ANNALS OF SURGERY (2007)
A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C-difficile-associated disease in Quebec
Bruno Hubert et al.
CLINICAL INFECTIOUS DISEASES (2007)
tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile
Scott R. Curry et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile -: Associated diarrhea
Danny Lagrotteria et al.
CLINICAL INFECTIOUS DISEASES (2006)
Nitazoxanide for the treatment of Clostridium difficile colitis
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2006)
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile -: Associated diarrhea
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2006)
Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada
Duncan R. MacCannell et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea
Stuart McPherson et al.
DISEASES OF THE COLON & RECTUM (2006)
Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2006)
Clostridium difficile - Associated disease: An emerging threat to patient safety - Insights from the society of infectious diseases pharmacists
RC Owens
PHARMACOTHERAPY (2006)
Rifaximin: A novel nonabsorbed rifamycin for gastrointestinal disorders
JA Adachi et al.
CLINICAL INFECTIOUS DISEASES (2006)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Invasive Saccharomyces infection:: A comprehensive review
A Enache-Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2005)
In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis
DM Citron et al.
ANAEROBE (2005)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clostridium difficile toxoid vaccine in recurrent C-difficile-associated diarrhea
S Sougioultzis et al.
GASTROENTEROLOGY (2005)
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole
T Peláez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A large outbreak of Clostridium Difficile -: Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use
CA Muto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Alternative treatments for Clostridium difficile disease:: what really works?
LV Mcfarland
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Outbreak of Clostridium difficile infection in a long-term care facility:: Association with gatifloxacin use
R Gaynes et al.
CLINICAL INFECTIOUS DISEASES (2004)
Rifalazil treats and prevents relapse of Clostridium difficile-associated diarrhea in hamsters
PM Anton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on Probiotic L-Rhamnosus GG
MK Salminen et al.
CLINICAL INFECTIOUS DISEASES (2004)
In vitro activity of OPT-80 against clostridium difcile
G Ackermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea
MH Wilcox
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism
M Cassone et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
J Aas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A
S Aboudola et al.
INFECTION AND IMMUNITY (2003)
When is an emergency department not an emergency department?
S Collinson et al.
BRITISH MEDICAL JOURNAL (2002)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
AL D'Souza et al.
BRITISH MEDICAL JOURNAL (2002)
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
T Lherm et al.
INTENSIVE CARE MEDICINE (2002)
Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications
RM Dallal et al.
ANNALS OF SURGERY (2002)
Clostridium difficile infection in patients with neutropenia
M Gorschlüter et al.
CLINICAL INFECTIOUS DISEASES (2001)
GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis
CB Kurtz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Intravenous metronidazole for the treatment of Clostridium difficile colitis
F Friedenberg et al.
DISEASES OF THE COLON & RECTUM (2001)
Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults
KL Kotloff et al.
INFECTION AND IMMUNITY (2001)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
The search for a better treatment for recurrent Clostridium difficile disease:: Use of high-dose vancomycin combined with Saccharomyces boulardii
CM Surawicz et al.
CLINICAL INFECTIOUS DISEASES (2000)
In vitro and in vivo activities of nitazoxanide against Clostridium difficile
CS McVay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
